The SMR Jewels IPO allotment status is expected to be available on June 4, 2026,…

Goldline Pharmaceutical IPO Allotment Status 2026: Check Date, Link & Steps
The Goldline Pharmaceutical IPO allotment status will be available on the allotment date on May 15, 2026, Friday. The Goldline Pharmaceutical IPO subscription closed on May 14, 2026, Thursday.
Investors who applied for the IPO will be able to check the Goldline Pharmaceutical IPO allotment status online through the Bigshare Services Pvt. Ltd. website or the BSE website. The IPO received an overall subscription of 840.74 times. The IPO GMP was around ₹15 after the subscription ended.

How to Check Goldline Pharmaceutical IPO Allotment Status
On Registrar Website (Goldline Pharmaceutical )
Step 1: Visit the Goldline Pharmaceutical
Step 2: Select Goldline Pharmaceutical from the dropdown list
Step 3: Enter any one of the required details: PAN number, Application Number, or Demat Account Number
Step 4: Click on the “Search” button
Step 5: Your allotment status will be displayed on the screen
On BSE Website
Step 1: Visit the Bombay Stock Exchange website
Step 2: Go to ‘Investor Services’ and click on ‘Status of Issue Application’
Step 3: Select ‘Application Status Check’
Step 4: Choose the Issue Type and Issue Name (Mehul Telecom IPO)
Step 5: Enter your PAN number or Application Number
Step 6: Complete the “I’m not a robot” verification
Step 7: Click on “Search” to view your allotment status
On NSE Website
Step 1: Visit the National Stock Exchange of India website
Step 2: Click on ‘Invest’ in the top menu (or search for “Verify IPO Bids”)
Step 3: Under Resources & Tools, select “Verify IPO Bids / IPO Bid Verification”
Step 4: Choose Mehul Telecom IPO from the dropdown menu
Step 5: Enter your Application Number or PAN
Step 6: Fill in additional details if required (such as DP ID)
Step 7: Complete the CAPTCHA verification
Step 8: Click on “Submit/Verify” to check your allotment status
About Company
Goldline Pharmaceutical Ltd. is a fast-growing pharmaceutical company operating across multiple states in India, including Maharashtra, Chhattisgarh, Madhya Pradesh, Odisha, Tamil Nadu, Rajasthan, Jharkhand, Goa, and Bihar. The company focuses on delivering quality healthcare products and expanding its presence in the pharmaceutical distribution and supply sector. With a strong operational network, Goldline Pharmaceutical aims to ensure better availability of medicines and healthcare solutions across various regions, supporting both urban and semi-urban markets.
Over the years, the company has been steadily expanding its business footprint and strengthening its supply chain capabilities to match growing market demand. Goldline Pharmaceutical is committed to scaling its operations by improving inventory management and enhancing product availability year by year. With a focus on consistent growth, the company continues to build a strong foundation in the healthcare industry while expanding its reach across new territories in India.